Clinical Trial: An Exploratory Clinical Study Of Bempemab Combined With Anlotinib As First-Line Treatment For Elderly Patients With Locally Advanced Or Metastatic Non-Small-Cell Lung Cancer

U.S., Oct. 1 -- ClinicalTrials.gov registry received information related to the study (NCT07849712) titled 'An Exploratory Clinical Study Of Bempemab Combined With Anlotinib As First-Line Treatment For Elderly Patients With Locally Advanced Or Metastatic Non-Small-Cell Lung Cancer' on Sept. 18.

Brief Summary: This exploratory clinical study evaluates the efficacy and safety of combining benmelstobart (a PD-L1 inhibitor) with anlotinib (a multi-target anti-angiogenic TKI) as a first-line, chemotherapy-free treatment for elderly patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).

Study Start Date: Oct. 01

Study Type: INTERVENTIONAL

Condition: Non-small Cell Lung Cancer (NSCLC) Stage IV Locally Advanced Non-Sm...